MARKET

CSCIF

CSCIF

Cosciens Biopharma Inc
OTCMQB
5.30
NaN%
Suspension 09:30 09/10 EDT
OPEN
--
PREV CLOSE
5.30
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
12.21
52 WEEK LOW
2.374
MARKET CAP
5.63M
P/E (TTM)
0.938
1D
5D
1M
3M
1Y
5Y
1D
COSCIENS Biopharma Swings to First-Half Profit and Cuts Costs as It Exits SEC Reporting
TipRanks · 08/11 22:08
COSCIENS Biopharma: Q2 Earnings Snapshot
Barchart · 08/11 16:53
About CSCIF
COSCIENS Biopharma Inc. is a Canada-based life science company. The Company is developing and commercializing a diversified portfolio of products for the cosmeceutical, nutraceutical and pharmaceutical markets. The Company’s patented technologies include the Pressurized Gas eXpanded (PGX) technology, which is a technology that generates high-value yields of active ingredients from natural-based resources for use in novel cosmeceutical, nutraceutical and pharmaceutical products. The Company's two products, oat beta glucan and avenanthramides, are found in household-name cosmetic and personal care brands. These products are manufactured from the Company’s proprietary oat extraction manufacturing technology and are known for their well-documented health benefits. Its lead product, macimorelin (Macrilen; Ghryvelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).

Webull offers COSCIENS Biopharma Inc (USA) stock information, including OTCMQB: CSCIF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSCIF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSCIF stock methods without spending real money on the virtual paper trading platform.